MedTrace Logo

A Real Life Evaluation of the Performance of a Large Volume Nebulizer

NCT00632112 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2009-06-05

No results posted yet for this study

Summary

Continuous albuterol has become the standard of care for patients in status asthmaticus. We have previously performed an in-vitro study comparing 4 different brands of continuous nebulizers. We now want to compare the in-vitro with the in-vivo performance of the brand we use. we hypothesize that there will be no difference between in-vivo and in-vitro results.

Conditions

Sponsors & Collaborators

  • S&T Medical Technologies, Inc.

    collaborator INDUSTRY

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • Ariel Berlinski, M.D. · University of Arkansas

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00632112 on ClinicalTrials.gov